NDC 31722-506-05
LAMIVUDINE and ZIDOVUDINE 150 mg/1
LAMIVUDINE and ZIDOVUDINE · TABLET, FILM COATED
Lamivudine and zidovudine is a combination medication taken by mouth to treat hepatitis B virus infection. It belongs to a class of drugs called nucleoside analog reverse transcriptase inhibitors, which work by slowing the virus's ability to reproduce.
Key Facts
- Brand Name
- LAMIVUDINE and ZIDOVUDINE
- Generic Name
- LAMIVUDINE and ZIDOVUDINE
- NDC Code (Package)
31722-506-05- NDC Code (Product)
31722-506- Manufacturer
- Camber Pharmaceuticals, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA079124
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 09/18/2015
Recall History
No Recall HistoryView Full Drug Page
LAMIVUDINE and ZIDOVUDINE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.